Science Current Events | Science News | Brightsurf.com
 

Hypothermia remains effective in cardiac arrest patients with preexisting cardiomyopathy

November 15, 2011
Cardiomyopathy is common among cardiac arrest survivors. The survival and neuroprotective benefits of therapeutic hypothermia is similar in patients with preexisting cardiomyopathy, compared with those patients without cardiomyopathy, according to a scientific poster being presented Nov. 14 at the at the American Heart Association (AHA) scientific sessions in Orlando, Fla. Therefore, the researchers recommended the use of therapeutic hypothermia in patients with the preexisting condition.

"While it is well established that therapeutic hypothermia is neuroprotective and increases survival in resuscitated cardiac arrest patients without cardiomyopathy, we sought to determine whether catastrophic outcomes in cardiac arrest patients with preexisting cardiomyopathy are avoidable," said Michael R. Mooney, MD, a cardiologist at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis and physician researcher with Minneapolis Heart Institute Foundation.

From February 2006 to July 2010, Mooney and his colleagues enrolled 192 consecutive cardiac arrest patients who remained unresponsive following return of spontaneous circulation in a therapeutic hypothermia protocol, regardless of initial rhythm, hemodynamic status or prior medical history. They hypothesized that there would be a high prevalence of preexisting cardiomyopathy in this patient population, and therapeutic hypothermia would confer similar neurologic and survival benefit compared to non-cardiomyopathy patients.

Of the 192 patients, 43.8 percent had preexisting cardiomyopathy, of which ischemic was the most common type (41.7 percent). Patients with preexisting cardiomyopathy were older (65.7 years vs. 61.7 years) and more likely to be male (83.3 vs. 63.9 percent).

The majority presented in ventricular fibrillation/ventricular tachycardia (75 percent and 70.4 percent) in both the cardiomyopathy and non-cardiomyopathy groups. There was a higher prevalence of concurrent STEMI in the cardiomyopathy group (27 vs. 18.5 percent), which was not statistically significantly. Cardiogenic shock was more prevalent in the cardiomyopathy group (54.8 vs. 28.7 percent).

While the cardiomyopathy groups were slightly higher, the survival between the two groups (52.4 vs. 51.9 percent) and survival with favorable neurologic outcome, defined by Cerebral Performance Category 1 or 2, (46.4 vs. 49.1 percent), were similar. They found that survival with favorable neurologic outcome in cardiomyopathy patients with cardiogenic shock was 34.8 percent, compared with 45.2 percent in non-cardiomyopathy cardiogenic shock patients.

"The incidence of preexisting heart dysfunction in this observational study is alarming. In general, we need to employ a more careful surveillance and improve our adherence to the clinical guidelines, as less than 50 percent of patients who currently qualify for automatic implantable cardioverter-defibrillators actually receive them," Mooney said. "A great deal more research is warranted in assessing this patient population."

Minneapolis Heart Institute Foundation


Related Cardiomyopathy Current Events and Cardiomyopathy News Articles


Treatment outlook for adults with hypertrophic cardiomyopathy move from grim to good
Newly published research led by the Minneapolis Heart Institute Foundation (MHIF) and Tufts Medical Center in Boston shows that implantable defibrillators (ICDs), along with other modern treatments, have reduced mortality rates and are helping patients with hypertrophic cardiomyopathy (HCM) live longer, including normal life expectancy.

In chronic heart failure, monitoring calcitriol may help prevent death
In patients with chronic heart failure, the vitamin D metabolite 1,25-dihydroxyvitamin D (1,25(OH)2D), also called calcitriol, and its ratio to parathyroid hormone (PTH 1-84) may help predict cardiovascular death; and patients with decreased calcitriol and decreased ratio of calcitriol to PTH might benefit from more aggressive supplementation, a new study finds.

Desmoplakin's tail gets the message
Cells control the adhesion protein desmoplakin by modifying the tail end of the protein, and this process goes awry in some patients with arrhythmogenic cardiomyopathy, according to a study in The Journal of Cell Biology.

UVA prevents diabetic heart condition by magnifying effect of exercise
A researcher at the University of Virginia School of Medicine has magnified a benefit of exercise in mice to provide a "profound" protection from diabetic cardiomyopathy, a potentially deadly heart condition that affects many people with diabetes.

Keeping the heart's engine in sync: Contractions' efficiency depends on critical protein
The human heart is a fine-tuned engine - more advanced than the finest Ferrari despite being simply designed by Mother Nature.

Leaky channels could contribute to unusual heart arrhythmias
Leaks are not just problems for plumbers and politicians; researchers in Canada reveal how leaky transmembrane channels could cause disruptions in normal heart function.

Drinking moderate amounts of alcohol is linked to reduced risk of heart failure
Evidence already exists for the beneficial effects of drinking moderate amounts of alcohol on the risk of developing a number of heart conditions; however, the role it plays in the risk of developing heart failure has been under-researched with conflicting results.

New hope for understanding sudden cardiac arrest
New biosciences research at the University of Kent could point the way to greater understanding of the heart mutations that cause sudden cardiac arrest.

Up to 8 percent of South Asians carry gene mutation that causes heart attacks
Up to 8 percent of people from India, Pakistan, Bangladesh and other South Asian countries carry a mutated gene that causes heart failure and potentially fatal heart attacks.

Targeting mitochondrial enzyme may reduce chemotherapy drug's cardiac side effects
Massachusetts General Hospital (MGH) investigators have identified two compounds that appear, in cellular and animal models, to block the cardiac damage caused by the important chemotherapy drug doxorubicin.
More Cardiomyopathy Current Events and Cardiomyopathy News Articles

A Guide to Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians

A Guide to Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians
by Barry J. Maron (Author), Lisa Salberg (Author)


Written by the authority on hypertrophic cardiomyopathy (HCM) and an HCM patient, and fully endorsed by the Hypertrophic Cardiomyopathy Association (HCMA), the leading advocacy and support organization, the 3rd Edition of this best-selling guide offers unparalleled insight into all aspects of living with and treating HCM.Accessible and practical, A Guide to Hypertrophic Cardiomyopathy For Patients, Their Families and Interested Physicians 3rd Edition: * Answers the most pressing questions posed by patients, their families, and non-specialists health professionals involved in their care * Covers everything from what is HCM and initial diagnosis of this increasingly prevalent condition to the latest treatment options * Reflects the first-ever HCM guidelines published by the American Heart...

Don't Take Heart Transplant For an Answer - Cardiomyopathy Treatment Action Plan

Don't Take Heart Transplant For an Answer - Cardiomyopathy Treatment Action Plan


Studies show that of all the organs in the human body, the heart is by far the most receptive to nutritional treatment.

After watching my son go to the cardiologist repeatedly and never seeing considerable improvement for his dilated cardiomyopathy, they were suggesting that a heart transplant would ultimately be the solution. I wasn’t about to simply stand by without researching as much as I could to help him. He had an ejection fraction of just 15%. A normal reading for this is 55% to 65%.

"Don't Take Heart Transplant for an Answer - Cardiomyopathy Treatment Action Plan" provides in-depth details about a congestive heart failure action plan that is relevant to the various types of cardiomyopathy, such as dilated, hypertrophic and restrictive...

Complete Medical Guide and Prevention for Heart Disease Volume IX; Cardiomyopathy

Complete Medical Guide and Prevention for Heart Disease Volume IX; Cardiomyopathy
by MedHealth


Heart is a muscular organ that located the center of the circulatory system. It pumps blood throughout body via blood vessels network, such as capillaries, arteries and veins. Blood is delivered to and from all parts of body by these blood vessels.

At the optimal rate required to function well, a healthy heart provides your entire body with the proper quantity of blood. If disease or injury impairs your heart, your body's organs won't obtain enough blood to operate regularly.

Cardiopathy, commonly known as cardiac disease or heart disease, is an hyponym for a various diseases affecting the heart. Since 2007, it is one of the major cause of death in the United States, Canada and some European countries such as England and Wales, representing about 25.4% of the total...

Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure

Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure
by Marc Silver (Author)


Up-to-date information on available and forthcoming medical and surgical treatments. How attitude and emotion affect heart failure-and what you can do to stay positive. Tips for adopting a heart-healthy diet and lifestyle. Ways to forge a positive wo

Peripartum And Postpartum Cardiomyopathy: A Cardiac Emergency For Pregnant Women

Peripartum And Postpartum Cardiomyopathy: A Cardiac Emergency For Pregnant Women



The author, Anner T. Porter, gives important medical information based on her personal experience of 19 years with this life-threatening disease called Peripartum and Postpartum Cardiomyopathy. In her book,"Peripartum and Postpartum Cardiomyopathy: A Cardiac Emergency for Pregnant Women", she gently explains in lay terms, the symptoms, treatments, risk levels, and warning signs of this illness as well as the different types of medical tests that can help save your life and your heart.

She discusses critical points on the effects of peripartum and postpartum cardiomyopathy. She includes the different types of medical tests that can provide critical information on this rare, life-threatening disease of unknown causes that affects healthy women of any racial...

Cardiomyopathy...Keeping you on Track

Cardiomyopathy...Keeping you on Track
by eBookIt.com


Non fiction. This book was written for the 20th anniversary of the Association known as Cardiomyopathy Australia and celebrated with the biennial seminar at the culmination of Cardiomyopathy Week 2014 that runs from September 7 to Saturday September 13.

This book tells the story of the beginnings of the Association and its founder, the late Robyn Bell. Details of what cardiomyopathy is, what types of this disease are known, members stories and helpful advice for patients and carers, are all explained in this book.

The Introduction to the book was written by the Cardiomyopathy Australia President, Alistair Kerr and the Foreword written by eminent Australian cardiologist Dr Mark Ryan.

  Cardiomyopathies: Classification, Evaluation and Management
by Bernard Tyler (Editor)


Cardiomyopathies are defined as myocardial disease which leads to abnormal heart muscle. This book presents a complete, up to date examination of the current information available regarding cardiomyopathies. It presents the complete cardiovascular system as a functional unit, and the various contributors to this book analyze pathophysiological mechanisms from diverse viewpoints, by giving a classification, evaluation and management of cardiomyopathies. This book presents a broad overview of cardiomyopathies which will be of interest to researchers in this field.

A  Simple  Guide  To  Cardiomyopathy,  Diagnosis, Treatment  And  Related Conditions (A Simple Guide to Medical Conditions)

A Simple Guide To Cardiomyopathy, Diagnosis, Treatment And Related Conditions (A Simple Guide to Medical Conditions)


Chapter 1

Cardiomyopathy

My mother had cardiomyopathy; so did her mother and brother both of whom died from heart failure.

My brother also had aortic regurgitation which had been treated but still has heart failure.

When I was 12 and down with mumps, I remembered my mother resting at home supposedly suffering from a mild heart attack after a strenuous period of school work.

The doctors all thought that she had ischemic heart disease.

When I was a medical student, I decided to have an ECG done on myself and found that I had mild right bundle branch block which was thought to be congenital and not serious at that time.

Medical students always have the tendency to think that they have the same disease...

Hypertrophic Cardiomyopathy: Foreword by Bernard Gersh and Historical Context by Eugene Braunwald

Hypertrophic Cardiomyopathy: Foreword by Bernard Gersh and Historical Context by Eugene Braunwald
by Srihari Naidu (Editor)


This book provides a comprehensive clinical review of Hypertrophic Cardiomyopathy (HCM), the most common genetic disorder of the heart characterized by dysfunctional contractility at the sarcomere level, resulting in the development of abnormal and occasionally focal hypertrophy on a macroscopic level. Editor, Srihari S. Naidu, has brought together a world renowned group of experts to review various different topics but, with a practical focus that will enable readers to establish the evidence-based best practice in any potential scenario. Treatment modalities including medications, pacemakers and defibrillators, and invasive septal reduction therapy (both surgical myectomy and alcohol septal ablation) will be discussed. Chapters on genetics, family screening, lifestyle concerns, and...

Recent Views on Hypertrophic Cardiomyopathy (Developments in Cardiovascular Medicine)

Recent Views on Hypertrophic Cardiomyopathy (Developments in Cardiovascular Medicine)
by E. van der Wall (Editor), K.J. Lie (Editor)


In Groningen there has been a continuous investigation of hypertrophic cardio­ myopathy for almost twenty years. Members of this working-group have tried to study the many aspects of this intriguing disease, and it is in this volume that they present their recent results and current concepts (chapters 2, 3, 5 and 6). A contribution from the Dutch interuniversity Institute of Cardiology presenting a detailed account of evaluation by means of radionuclide techniques completes the non-invasive picture of cardiomyopathies (chapter 4). On July 6th, 1984, a symposium entitled 'Recent views on hypertrophic cardio­ myopathy' was held at the University Hospital Groningen. The main reason to organize this meeting was the retirement of one of our working-group members, namely E. van der Wall, as...

© 2015 BrightSurf.com